DBVT News and Press, DBV Technologies S.A. From 09/21/20

Nikola Corporation (NKLA) -26% after Milton resignation sends shockwaves.Eastman Kodak (KODK) -11%.Uranium Energy (UEC) -9%.Eton Pharmaceuticals (ETON) -7%.Deutsche Bank Aktiengesellschaft (DB) -7% on money laundering allegations.ING Groep N.V. (ING) -7%.Plug Power (PLUG) ...

AIMT's stock fell precipitously amid the COVID-19 pandemic, despite receiving FDA approval for its Palforzia treatment (the first FDA approved treatment for peanut allergies). Nestle has commenced a tender offer to purchase shares of AIMT at $34.50 per share and it is trying to take a...

Monthly information regarding the total number of voting rights and  total number of shares of the Company as of August 31, 2020 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN Code: FR 00...

Marinus Pharmaceuticals (NASDAQ: MRNS )   +61%  after ganaxolone successful in pivot study in rare type of epilepsy. More news on: Marinus Pharmaceuticals, Inc., Plus Therapeutics, Inc., Tiziana Life Sciences PLC, Stocks on the move, , Read more ...

DBV Technologies (NASDAQ: DBVT ) appoints  Sebastien Robitaille as CFO effective October 2. More news on: DBV Technologies S.A., Healthcare stocks news Read more ...

Montrouge, France, September 9, 2020 DBV Technologies Announces Leadership Changes DBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Ramzi Benamar, Chief Financial Officer, and Kev...

Montrouge, France, September 2, 2020 DBV Technologies to Participate in Multiple September Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced its participatio...

Aimmune Therapeutics (NASDAQ: AIMT ) +171%  on being acquired by Nestle. More news on: Aimmune Therapeutics, Inc., Akcea Therapeutics, Inc., Genworth Financial, Inc., , , Read more ...

Monthly information regarding the total number of voting rights and  total number of shares of the Company as of July 31, 2020 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN Code: FR 0010...

Investors had high expectations for Aimmune Therapeutics (NASDAQ: AIMT) at the beginning of the year. Its stock performed well in 2019 -- with its shares surging by more than 30% -- and the biotech was on the verge of getting approval from the U.S. Food and Drug Administration (FDA) for Palf...